je.st
news
Underwriters buy additional $658 mln in Teva Pharm shares
2016-01-03 12:51:22| Biotech - Topix.net
Jan 3 The underwriters for Teva Pharmaceutical Industries' share offering last month have exercised their over-allotment option to purchase additional shares worth $658 million. Teva, the world's biggest generic drugmaker, will use the funds to finance the cash portion of its planned $40.5 billion purchase of Allergan PLC's Actavis generics business.
Tags: buy
additional
shares
additional buy
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||